Small-Bore Connectors Market By Product (Luer Slip Connectors, Luer Lock Connectors, ENFit Connectors, NRFit Connectors, Respiratory Connectors, Limb-Cuff Connectors, Other Specialized Connectors), By Application (Intravascular and Hypodermic, Enteral Feeding, Neuraxial and Regional Anaesthesia, Breathing Systems and Medical Gases, Blood-Pressure and Limb-Cuff Inflation, Other Clinical Applications), By End User (Hospitals and Critical Care Units, Ambulatory Surgical Centres, Specialty Clinics, Home Healthcare Settings, Medical Device Manufacturers), By Geography, Segment Revenue Estimation, Forecast: 2026–2032

Small Bore Connectors Market: Standard-Specific Conversion Is Reshaping High-Volume Medical Consumables

The Global Small-Bore Connectors Market was valued at approximately USD 650 million in 2025 and is projected to reach USD 885 million by 2032, expanding at a CAGR of 4.5% during 2026–2032, according to internal projections by Strategic Market Research.

 

Small-bore connectors are medical-device interfaces under 8.5 mm used to link tubing, syringes, catheters, feeding systems and gas-delivery devices in patient care. The market includes both standalone connectors and those built into disposable sets, extension lines, valves and procedure kits. The FDA and global regulatory bodies align around the ISO 80369 series as the approved framework, which replaces traditional Luer designs with application-specific, non-interconnectable geometry to prevent misconnections. Approved classifications include ISO 80369-2 (breathing systems/gases), ISO 80369-3 (enteral/ENFit), ISO 80369-5 (limb cuff/blood pressure), ISO 80369-6 (neuraxial/regional anesthesia), and ISO 80369-7 (intravascular/hypodermic). Application-specific shapes and locking mechanisms prevent unrelated clinical delivery lines from being connected, reducing dependence on colour coding or staff recognition alone.

 

The global use of small-bore connectors is extensive, with over 3.8 million dialysis patients and hundreds of millions of patients receiving IV therapy, injections, or enteral feeding. Hospitals and critical care units remain the largest users, accounting for about 56% of demand and roughly USD 364 million in 2025 revenue. This segment is expected to grow at around 4.7% through 2032, driven by ongoing use in infusion, feeding, anaesthesia, and respiratory care. Safety concerns are a key driver, with a 2023–2024 survey showing that 47% of clinicians experienced a tubing misconnection or near miss, highlighting the need for safer, incompatible connector systems.

 

Luer Connectors Remain the Market’s Highest-Volume Product Base

ISO 80369-7:2021 covers Luer slip and Luer lock connectors for intravascular and hypodermic products, including syringes, needles and intravenous cannulae. Luer slip products use a tapered friction connection, while Luer lock products add a threaded collar to improve connection security. Because ISO 80369-7 preserves interoperability across intravenous devices, this category remains the principal connection architecture for infusion therapy.

Intravascular and hypodermic Luer connectors represented an estimated 57% of the global market and generated approximately USD 370.5 million in 2025. The segment is projected to expand at a CAGR of nearly 3.8% during 2026–2032. Its growth rate remains below that of newer application-specific designs because Luers are already deeply established across global infusion systems, but their large installed base preserves the highest absolute revenue contribution.

The scale of vascular access makes Luer connectors the dominant product in the market. With over 170 million peripheral IV catheters placed each year, a single procedure typically requires multiple connector-based components such as hubs, extension lines, syringes, and administration sets, driving high recurring demand tied to hospital activity and infusion volumes.

However, Luer compatibility has also been a key safety concern. A 2023–2024 clinician survey found that IV-to-enteral misconnections accounted for 39% of reported incidents, while IV-to-neuraxial errors made up 22%. In response, Luers are now largely restricted to IV and hypodermic use, while other routes are being shifted to incompatible systems like ENFit and NRFit to reduce cross-connection risks.

 

ENFit Conversion Creates a Large Enteral Replacement Cycle

ISO 80369-3:2016 defines connector dimensions and performance requirements for enteral feeding sets, drainage sets, syringes and patient-access devices. ENFit connectors are mechanically incompatible with IV Luer ports, preventing feeding formula or liquid medication from being attached directly to an intravenous line. The design is now incorporated across feeding tubes, pump sets, gravity sets, extensions and enteral syringes.

Enteral and ENFit connectors accounted for an estimated 22% of market revenue, equivalent to approximately USD 143 million in 2025. The segment is projected to grow at a CAGR of nearly 5.1% through 2032, supported by continuing conversion in the United States, developing healthcare systems and home-enteral nutrition channels.

The safety evidence continues to drive replacement. A historical review identified 116 enteral misconnections and 21 deaths, equal to an 18% mortality rate among the documented cases. A later review identified 96 additional incidents, of which 4% resulted in death and 69% caused non-fatal harm. These figures represent reported cases rather than population-level incidence, but they support hospital investment in complete ENFit systems instead of continued dependence on transition adapters.

Conversion is advanced but incomplete. Among clinicians surveyed in 2023–2024, 48% said their organisations had completed ENFit conversion, 16% were converting and 11% planned to transition. Seven percent had no conversion plan, while 18% were unfamiliar with ENFit. Directional industry estimates placed adoption above 60% in the United States, close to complete conversion in Europe and approximately 80% in Australia and New Zealand.

 

NRFit Is the Next Major Safety-Led Conversion Opportunity

ISO 80369-6:2025 covers connectors for neural applications, including spinal, epidural, intrathecal and regional anaesthesia procedures. NRFit connectors use a smaller and distinct connection profile that prevents intravenous or enteral equipment from attaching to neuraxial devices.

NRFit and other neuraxial connectors represented approximately 8% of the market and generated an estimated USD 52 million in 2025. The segment is projected to expand at approximately 7.0% during 2026–2032, making it the fastest-growing application category as hospitals replace Luer-compatible spinal and epidural systems.

A review covering 1999–2019 identified 133 neuraxial misconnection cases and 26 deaths. Epidural medication delivered into an IV line accounted for 29% of events, while IV medication delivered into an epidural line represented 28%. These wrong-route incidents can cause neurological injury, seizures, paraplegia or death, making conversion commercially important despite lower procedure volumes than intravenous or enteral applications.

Adoption remains substantially behind ENFit. Only 9% of surveyed organisations had completed NRFit conversion, another 9% were converting and 16% planned to transition. Approximately 53% of respondents were unfamiliar with NRFit, and incomplete product availability remained a major barrier.

NHS England instructed relevant providers to complete the transition for intrathecal, epidural and regional-block procedures by January 31, 2025. Ireland’s HSE issued a national alert in November 2025 and established November 26, 2027 as the completion date. Hospital conversion requires alignment across spinal needles, epidural catheters, syringes, filters, extension lines, pumps and prepared procedure kits.

 

Respiratory and Limb-Cuff Standards Broaden the Addressable Market

ISO 80369-2:2024 created separate respiratory connector designs for breathing systems and driving gases. The R1 connector covers devices operating at pressures up to 15 kPa, while R2 addresses applications operating between 15 kPa and 600 kPa, including higher-pressure oxygen-delivery tubing. The standard creates mould-conversion, product-redesign and validation requirements across ventilator accessories, airway-management equipment and medical-gas systems. The FDA formally recognised the standard in 2025.

Respiratory, limb-cuff and other specialised connector applications collectively represented an estimated 13% of the global market and generated approximately USD 84.5 million in 2025. These applications are projected to grow at a CAGR of nearly 4.8% through 2032 as respiratory-device manufacturers implement ISO 80369-2 and hospitals replace legacy pneumatic and gas-delivery interfaces.

The clinical incident mix provides a measurable reason for conversion. Enteral-to-respiratory connections represented 7% of events reported in the clinician survey, IV-to-respiratory events accounted for 4%, and IV-to-limb-cuff events represented 6%. Incorrectly connecting enteral formula to a respiratory line can introduce liquid into the airway, while attaching a pressurised cuff line to an IV system creates an air-embolism risk.

IEC 80369-5:2016 covers interfaces used for blood-pressure cuffs, compression systems and other limb-cuff inflation products. Urinary connections accounted for approximately 2% of reported enteral cross-connections, but urinary devices do not yet have the same coordinated published standard-driven conversion pathway as enteral, neural, respiratory, limb-cuff and intravascular products.

 

Testing Requirements Raise Entry Barriers

The standards framework includes ISO 80369-1:2025 for general interface requirements and ISO 80369-20:2024 for common performance-test methods. Manufacturers must evaluate connector geometry, non-interconnectability, leakage performance, separation resistance, stress cracking and material compatibility. ISO 80369-20 is fully recognised by the FDA as a common testing framework for connector performance.

Connectors must also remain functional following bonding, assembly, sterilisation and ageing. A component that passes dimensional inspection before integration can behave differently after it is incorporated into a syringe, catheter or administration set. Compliance therefore raises expenditure on precision moulding, quality control, regulatory documentation and finished-device validation.

 

Regional Analysis

North America

North America is the largest regional market, accounting for about 44.5% of global small-bore connector revenue in 2025, or roughly USD 289.3 million. The region is expected to grow at around 4.0% CAGR through 2032, driven by ongoing ENFit and NRFit adoption alongside steady Luer-based demand.

The United States dominates the region with over 83% share, equal to about USD 240.1 million in 2025. This is supported by a high-volume hospital system and more than 170 million annual peripheral IV catheter insertions, which sustain strong demand for Luer connectors and related consumables.

Adoption of safety standards is progressing but uneven. ENFit conversion is about 48% complete, while NRFit adoption remains low at 9% among surveyed organisations. With no single nationwide rollout mandate, hospitals continue to adopt ISO 80369 systems at different speeds, creating demand for suppliers that offer full compatibility and implementation support.

 

Europe

Europe accounted for an estimated 26% of global market revenue, equivalent to approximately USD 169 million in 2025, and is projected to expand at a CAGR of around 4.0% through 2032. The region leads ENFit adoption and has used national procurement policies and safety alerts to accelerate NRFit implementation. NHS England’s January 31, 2025 deadline created a defined replacement event across relevant NHS-funded providers.

Ireland recorded 20 incidents between January 2023 and June 2024 in which a drug was connected to the wrong access. The HSE determined that seven of those incidents may have been prevented through NRFit connectors and established November 26, 2027 as the implementation deadline. These coordinated programmes favour manufacturers able to supply nationally available product portfolios rather than isolated connector components.

 

Asia-Pacific

Asia-Pacific accounted for about 21% of the global market, or roughly USD 136.5 million in 2025, and is expected to grow the fastest at around 5.9% CAGR through 2032. Growth is driven by increasing adoption of ISO 80369 standard connectors, especially in Japan, Australia, and New Zealand, where ENFit and NRFit transitions are already well advanced. Japan has phased out legacy neuraxial products since 2020, while Australia and New Zealand have issued formal guidance supporting connector standardisation.

Across the wider region, adoption is still uneven, with many hospitals in less centralised healthcare systems gradually shifting to application-specific connectors as they replace feeding, infusion, and anaesthesia equipment rather than through full system-wide upgrades.

 

Latin America, Middle East and Africa

Latin America, the Middle East and Africa together accounted for about 8.5% of global revenue, or roughly USD 55.3 million in 2025, and are expected to grow at around 5.0% through 2032. Growth is driven by gradual replacement of older infusion, feeding, and anaesthesia systems.

Adoption of small-bore connector standards is slower and less structured than in North America and Europe, with most hospitals upgrading only when new equipment is purchased rather than through coordinated national programmes.

This creates a longer but steady demand cycle for compatible transition sets and accessories, with suppliers needing to adapt to varied regulatory environments and uneven procurement systems across the region.

 

Competitive Landscape

Competition is split between large medical consumables companies and specialised connector suppliers, with full product portfolios becoming more important than individual connector design.

B. Braun has completed over 3,000 NRFit hospital conversions globally, supported by a full range of spinal, epidural, syringe and infusion products that enable complete system switching.

Cardinal Health’s Kangaroo platform supports ENFit adoption with feeding tubes, pump sets, extensions and Monoject syringes in multiple sizes for neonatal to adult care.

Vygon offers both ENFit and NRFit solutions, including syringes, needles and complete epidural sets, helping hospitals standardise across procedures.

ICU Medical focuses on IV and enteral safety systems, including needle-free IV platforms and the ENFit Lopez Valve, which prevents cross-connection between delivery lines.

Overall, competition is driven by supply reliability, regulatory support and training, as many hospitals are still transitioning—NRFit awareness remains low and full conversion is limited, creating ongoing growth opportunities.

 

Market Outlook

ISO 80369-7 Luer connectors will remain the largest category, with an estimated 57% market share and USD 370.5 million in 2025 revenue, because of more than 170 million annual peripheral IV catheter insertions and the multiple disposable connections required for each vascular-access episode.

NRFit is positioned for the fastest incremental growth at approximately 7.0%, compared with 5.1% for ENFit and 3.8% for Luer connectors. Respiratory and specialised connectors are projected to expand at approximately 4.8% following publication of ISO 80369-2:2024. Asia-Pacific is expected to record the fastest regional growth at approximately 5.9%, while North America will retain the largest revenue contribution.

 

 Small Bore Connectors Market Report Coverage Table

Report Attribute	Details
Forecast Period	2026–2032
Market Size Value in 2025	USD 650 Million
Revenue Forecast in 2032	USD 885 Million
Overall Growth Rate	CAGR of 4.5% (2026–2032)
Base Year for Estimation	2025
Historical Data	2019–2024
Unit	USD Million, CAGR (2026–2032)
Segmentation	By Product, By Application, By End User, By Geography
By Product	Luer Slip Connectors, Luer Lock Connectors, ENFit Connectors, NRFit Connectors, Respiratory Connectors, Limb-Cuff Connectors, Other Specialized Connectors
By Application	Intravascular and Hypodermic, Enteral Feeding, Neuraxial and Regional Anaesthesia, Breathing Systems and Medical Gases, Blood-Pressure and Limb-Cuff Inflation, Other Clinical Applications
By End User	Hospitals and Critical Care Units, Ambulatory Surgical Centres, Specialty Clinics, Home Healthcare Settings, Medical Device Manufacturers
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Country Scope	U.S., Canada, UK, Germany, France, Italy, Ireland, China, Japan, South Korea, India, Australia, New Zealand, Brazil, Mexico, Saudi Arabia, UAE, South Africa
Market Drivers	ISO 80369 standard-specific conversion, rising focus on preventing tubing misconnections, continued ENFit and NRFit adoption, high recurring demand for infusion and enteral consumables, respiratory connector redesign requirements, hospital replacement of legacy Luer-compatible systems
Customization Option	Available upon request